Direct-to-patient biospecimen and health data collection
Joined Bio - JB-MR-250225, Direct to Patient Minimal Risk Research
This project collects biospecimens, health and lifestyle information from adults (including healthy volunteers and people with conditions like lupus, celiac disease, or chronic kidney disease) to connect them with researchers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100000 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Joined Bio Industry-sponsored |
| Locations | 1 site (Lexington, Massachusetts) |
| Trial ID | NCT07128966 on ClinicalTrials.gov |
What this trial studies
Joined Bio enrolls consenting adults and collects de-identified health information, lifestyle surveys, and minimal-risk biospecimens for use by qualified research partners. Participation is remote-friendly and focused on matching people with specific health profiles to research requests rather than providing medical treatment. Collected samples and data are linked to researcher queries to accelerate development of diagnostics and therapies. The program also includes optional interviews and surveys to contribute additional patient-centered data.
Who should consider this trial
Good fit: Adults aged roughly 18–90 who can provide informed consent, are willing to provide requested biospecimens and data, and meet specific requested health profiles (including healthy controls or diagnoses of interest).
Not a fit: People seeking direct therapeutic benefit, children, prisoners, or anyone unable to provide the requested specimens or consent are unlikely to gain medical benefit from participation.
Why it matters
Potential benefit: If successful, this program could speed development of new tests and treatments by giving researchers access to diverse biospecimens and de-identified health data.
How similar studies have performed: Participant-driven biobanks and registries (for example, All of Us and UK Biobank) have demonstrated that centralized biospecimen and data collection can meaningfully advance research, so this approach is established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, that are adults \[have reached the Age of Majority = aged 18 to 90 in most US states; aged 19-90 in Alabama or Nebraska; aged 21-90 in Mississippi or Puerto Rico\]. * Have reviewed and signed a consent or e-consent form for this study. If a person with diminished decision-making capacity, their Legally Authorized Representative has reviewed and signed the consent for on their behalf. * Be willing to comply with all study procedures and be available for the duration of the study. * Meets requirements of a current request for research participation (e.g. has previous diagnosis of a medical condition of interest or laboratory results within a specific range). * Pregnant women may be enrolled in this study in accordance with 45 CFR Part 46 Subpart B. Exclusion Criteria: * Unable to meet the Inclusion Criteria listed above. * Prisoners or children * Unable to provide the requested biospecimen(s), data or feedback without placing the individual at risk.
Where this trial is running
Lexington, Massachusetts
- Joined Bio — Lexington, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Chris Ianelli, MD — Joined Bio
- Study coordinator: Emily L Hubbard, BS Biology
- Email: ehubbard@joined.bio
- Phone: 12567970003
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.